Latvia - Cardiovascular System Medicine Use

Since 2014, Latvia Cardiovascular System Medicine Use grew 2.3% year on year. In 2019, the country was number 26 among other countries in Cardiovascular System Medicine Use with 313.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Latvia is overtaken by Israel, which was ranked number 25 at 316.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by South Korea with 217.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 726.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +0.4% compared to 2018. Germany, Czech Republic and Finland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +3.9% per year, while Slovakia witnessed the worst performance at -4.5% per year.

Loading...

Date Units (Defined Daily Dosage) Per Thousand Persons Per Day
2019 313.30
2018 298.60
2017 297.80
2016 283.70
2015 282.50
Download all data from 2012 to 2019

How does Latvia rank in Cardiovascular System Medicine Use?

# 28 Countries Units (Defined Daily Dosage) Per Thousand Persons Per Day Last YoY 5‑years CAGR
1 #1
Hungary
727 2019 +0.4 % +0.2 % View data
2 #2
Germany
713 2019 +2.2 % +0.8 % View data
25 #25
Israel
317 2019 -0.4 % -1.1 % View data
26 #26
Latvia
313 2019 +4.9 % +2.3 % View data
27 #27
South Korea
217 2019 -0.5 % +0.5 % View data
Compare all 28 countries

Go Top